| Product Code: ETC7546625 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India levodopa market import shipments experienced a healthy CAGR from 2020 to 2024, indicating steady growth. However, there was a notable decline in growth rate between 2023 and 2024, suggesting a temporary slowdown in market expansion. Overall, the market trend showcases a positive momentum with a slight dip in growth in the most recent period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Levodopa Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Levodopa Market Revenues & Volume, 2021 & 2031F |
3.3 India Levodopa Market - Industry Life Cycle |
3.4 India Levodopa Market - Porter's Five Forces |
3.5 India Levodopa Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 India Levodopa Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 India Levodopa Market Revenues & Volume Share, By Distribution Channels, 2021 & 2031F |
4 India Levodopa Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in India |
4.2.2 Growing geriatric population in India |
4.2.3 Rising awareness about neurological disorders and their treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory approvals for new levodopa-based products |
4.3.2 Limited healthcare infrastructure and access to medication in rural areas of India |
4.3.3 Presence of alternative treatment options for Parkinson's disease |
5 India Levodopa Market Trends |
6 India Levodopa Market, By Types |
6.1 India Levodopa Market, By Form |
6.1.1 Overview and Analysis |
6.1.2 India Levodopa Market Revenues & Volume, By Form, 2021- 2031F |
6.1.3 India Levodopa Market Revenues & Volume, By Tablets, 2021- 2031F |
6.1.4 India Levodopa Market Revenues & Volume, By Capsules, 2021- 2031F |
6.1.5 India Levodopa Market Revenues & Volume, By Powder, 2021- 2031F |
6.1.6 India Levodopa Market Revenues & Volume, By Liquid, 2021- 2031F |
6.2 India Levodopa Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Levodopa Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 India Levodopa Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 India Levodopa Market, By Distribution Channels |
6.3.1 Overview and Analysis |
6.3.2 India Levodopa Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 India Levodopa Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 India Levodopa Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.5 India Levodopa Market Revenues & Volume, By Other, 2021- 2031F |
7 India Levodopa Market Import-Export Trade Statistics |
7.1 India Levodopa Market Export to Major Countries |
7.2 India Levodopa Market Imports from Major Countries |
8 India Levodopa Market Key Performance Indicators |
8.1 Prescription rates of levodopa medications by neurologists in India |
8.2 Patient adherence rates to levodopa treatment regimens |
8.3 Number of clinical trials conducted for levodopa-based products in India |
9 India Levodopa Market - Opportunity Assessment |
9.1 India Levodopa Market Opportunity Assessment, By Form, 2021 & 2031F |
9.2 India Levodopa Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 India Levodopa Market Opportunity Assessment, By Distribution Channels, 2021 & 2031F |
10 India Levodopa Market - Competitive Landscape |
10.1 India Levodopa Market Revenue Share, By Companies, 2024 |
10.2 India Levodopa Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |